SEC Form 4 · accession 0001209191-15-044055
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
K Peony Yu
Officer — VP, Clinical Development
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 8:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 14, 2015 | F | 2,712 | $21.39 | D | 202,692 | D | |
| Common StockF1 | May 15, 2015 | M | 4,000 | $2.90 | A | 206,692 | D | |
| Common StockF1 | May 15, 2015 | M | 4,000 | $3.50 | A | 210,692 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $2.90 | May 15, 2015 | M | 4,000 | D | — | Jun 9, 2020 | Common Stock | 4,000 | 0 | D |
| Stock Option (RIght to Buy)F2 | $3.50 | May 15, 2015 | M | 4,000 | D | — | Jun 7, 2021 | Common Stock | 4,000 | 8,000 | D |
Explanation of responses
- F1Includes 2,336 shares acquired on May 15, 2015 through the Issuer's Employee Stock Purchase Plan.
- F2Twenty percent of the shares subject to each option vests on the first anniversary of the vesting commencement date and 80% of the shares subject to each option vests in 16 substantially equal quarterly installments thereafter over for the following four years.